Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002152795 | SCV002418251 | likely benign | Focal segmental glomerulosclerosis 5; Charcot-Marie-Tooth disease dominant intermediate E | 2023-12-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002152795 | SCV002794734 | likely benign | Focal segmental glomerulosclerosis 5; Charcot-Marie-Tooth disease dominant intermediate E | 2021-12-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003456521 | SCV004184430 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | INF2: BP4, BP7 |